Elvitegravir/cobicistat/emtricitabine/tenofovir DF (Quad)...

Elvitegravir/cobicistat/emtricitabine/tenofovir DF (Quad) has durable efficacy and differentiated safety compared to atazanavir boosted by ritonavir plus emtricitabine/tenofovir DF at week 96 in treatment-naïve HIV-1-infected patients

Rockstroh, J, DeJesus, E, Henry, K, Molina, J, Gathe, J, Wei, X, Fordyce, M, Rhee, M, Szwarcberg, J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Journal:
Journal of the International AIDS Society
DOI:
10.7448/IAS.15.6.18220
Date:
November, 2012
File:
PDF, 179 KB
2012
Conversion to is in progress
Conversion to is failed